
COGNITUM
ARO Consortium
Learn more about the Team

-
Led by Prof. Dr. Luiz Rizzo - Director of Research and Development at Sociedade Beneficente Israelita Brasileira Albert Einstein.
-
The biggest ARO in Latin America, part of Hospital Israelita Albert Einstein , a top ranking Hospital. Total of 50 hospitals/clinics between private and publics institutions are part of Hospital Israelita Albert Einstein health system facilities in Brazil.
-
Design and delivering trials (full-service) in collaboration with industry and Ministry of Health since 2017 - more than 3 Mega trials as well as > 15 thousand patients enrolled in more than 80 centers;
-
100+ Staff delivering >31 trials in 10 therapeutic areas (mainly Cardiology and Oncology).
-
Access to Hospital Einstein physicians and technology hub (Innovation, teaching and Bid data) and a network of research sites in Brazil, LatAm and beyond.
-
Experience of working in Global trials and conducting trials as ARO responsible for LatAM with additional reach via close partnerships.
-
Led by Professor Kausik Ray and Professor Neil Poulter.
-
20-year history of designing and delivering trials (full-service) in collaboration with industry - both for Imperial-sponsored and Industry-sponsored research.
-
An ARO that is linked to the UKCRC registered Imperial Clinical Trials Unit.
-
Part of Imperial College London – a globally renowned university that specialises in science, technology and medicine.
-
Imperial has a greater proportion of world-leading research than any other UK university, according to the Research Excellence Framework (REF).
-
Access to Imperial academics and clinicians.
-
Experience of working directly in 20+ countries, with additional reach via close partnerships.


-
Led by Professor Dorairaj Prabhakaran
-
Focus of Clinical Trials include:
-
DRUG & SURGERY TRIALS (ADVANCE, STITCH, CORONARY, UMPIRE, TOPSPIN)
-
BEHAVIOURAL STRATEGY TRIALS (DISHA, LIVING, YOGA in in Cardiac Rehabilitation, Diabetes Prevention & Heart Failure)
-
QUALITY IMPROVEMENT TRIALS (CARRS, SimCard, mWELLCARE, ACS-QUIK, C-QIP, I-TREC)
-
-
Summary of Impact
-
Trials conducted: 17
-
Centres: 150+ / Investigators: 250+
-
Patients: 50,000+
-
Publications: 150+
-
Funding raised: ~US$ 12 million
-
-
Knowledge partner: Indian Clinical Trial and Education Network (INTENT)
-
National Clinical Research Awards: ISCR/ACCRI

-
UCT based Coordinating Center for Cardiovascular Disease based Clinical Trials and Registries in South African and sub-Saharan Africa
-
Currently led by Professor Mpiko Ntsekhe (Vice President-PASCAR)
-
UCT has been the number one ranked university in Africa and is 77th (best placed African University) in the world in clinical and health sciences.
-
Over a decade of designing and coordinating clinical trials and prospective registries in across sub-Saharan Africa
-
MRG/UCT based Investigators have been the Overall Principal Investigator, National PI, and/or Study Steering Committee Members for >21 Multi-center International Clinical Trials and Registries in cardiovascular disease
-
UCT-based investigators are global leaders in clinical trials in the areas of HIV Medicine and related infectious diseases

-
A leading clinical research organisation based in Sri Lanka.
-
Over 13 years of proven of track record in participating global studies for major global pharmaceutical organisations and academic institutions.
-
48 clinical trials (completed and ongoing) for global clients, across 12 therapeutic areas and 8000+ participants
-
Leading the recruitment and retention metrics for many studies, globally
-
ISO 9001:2015 and ISO 9001:27001 certified company
-
106 full time staff working closely with 300+ Investigators across 77 Investigator centres
-
Long successful collaboration with Clinical Trials Unit (CTU), Faculty of Medicine, University of Kelaniya
-
30+ client audits - No significant observations reported
-
Robust governance structure, guided by an accomplished board of directors and eminent international scientific advisory panel
-
Led by Professors Anushka Patel (global), Bruce Neal (Australia), Vivekanand Jha (India) and Otavio Berwanger (UK).
-
20+ year history of designing and conducting global clinical and community trials with academic and industry partners.
-
Affiliated with UNSW Sydney and in collaboration with Imperial College London and Manipal Academy of Higher Education in India.
-
More than 100 staff globally, based in Australia, China, India and Europe, currently delivering >90 trials in >40 countries and in >2,000 sites
-
Experience in >10 therapeutic areas across a range of different settings including in communities, in primary care and in tertiary environments.
